Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biorestorative Therapies Inc (NQ: BRTX )

3.020 -0.040 (-1.31%)
Streaming Delayed Price Updated: 3:53 PM EST, Jan 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,183
Open 3.090
Bid (Size) 2.610 (3)
Ask (Size) 3.130 (1)
Prev. Close 3.060
Today's Range 3.020 - 3.130
52wk Range 2.460 - 5.975
Shares Outstanding 3,673,629
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
2022 Was A Year Of Growth, Funding, And Positive Results For BioRestorative Therapies
By Faith Ashmore, Benzinga 
Via TheNewswire.com
Topics Intellectual Property
Exposures Intellectual Property
2022 Was A Year Of Growth, Funding, And Positive Results For BioRestorative Therapies
2022 Was A Year Of Growth, Funding, And Positive Results For BioRestorative Therapies 
Via News Direct

Performance

YTD
+11.03%
+11.03%
1 Month
+5.91%
+5.91%
3 Month
-11.58%
-11.58%
6 Month
-6.21%
-6.21%
1 Year
-15.88%
-15.88%

More News

Read More
2022 Was A Year Of Growth, Funding, And Positive Results For BioRestorative Therapies
Via Benzinga
BioRestorative Therapies Announces SBIR Phase I Grant to Explore the Therapeutic Effects of ThermoStem® Targeting Polycystic Ovary Syndrome as an Indication
From BioRestorative Therapies, Inc
Via Globe NewsWire
EXCLUSIVE: BioRestorative Secures Funding Support For Programs Against Polycystic Ovary Syndrome
Via Benzinga
BioRestorative Therapies Enters Agreement with Regenexx, Granting BRTX Exclusive License Rights for Intellectual Property Related to the Development and Commercialization of its BRTX-100® Disc Program to Treat Chronic Lumbar Disc Disease
From BioRestorative Therapies, Inc
Via Globe NewsWire
EXCLUSIVE: BioRestorative Therapies Gets Exclusive License Rights From Regenexx For Development Of BRTX-100 Disc Program To Treat Chronic Lumbar Disc Disease
Via Benzinga
BioMedNewsBreaks – BioRestorative Therapies Inc. (NASDAQ: BRTX) to Participate at RHK Capital Disruptive Growth Conference
Via Investor Brand Network
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
BioRestorative Therapies to Participate at the RHK Capital Disruptive Growth Conference on December 5-6, 2022
From BioRestorative Therapies, Inc
Via Globe NewsWire
Chronic Obstructive Pulmonary Disease (COPD) Market Expected to Reach $25 Billion By 2027
Via FinancialNewsMedia
The NIH Has Given BioRestorative Therapies A Stamp Of Approval
Via News Direct
The NIH Has Given BioRestorative Therapies A Stamp Of Approval
Via TheNewswire.com
The NIH Has Given BioRestorative Therapies A Stamp Of Approval
Via Benzinga
See What's Next For The Regenerative Medicine Field -- BioRestorative Intends to Lead The Pack In Stem Cell Therapies!
Via Benzinga
BioRestorative Therapies CEO Lance Alstodt to be Interviewed on Famela and Friends Talk Radio Show
From BioRestorative Therapies, Inc
Via Globe NewsWire
A Look At Some Of The Companies Innovating In the Cutting-Edge Regenerative Medicine Field
Via TheNewswire.com
A Look At Some Of The Companies Innovating In the Cutting-Edge Regenerative Medicine Field
Via News Direct
A Look At Some Of The Companies Innovating In the Cutting-Edge Regenerative Medicine Field
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2022
Via Benzinga
Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday
Via Benzinga
Why Sunlight Financial Shares Are Trading Lower By 59%, Here Are 54 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
BioRestorative Therapies to Present at the Dawson James Securities 7th Annual Small Cap Growth Conference
From BioRestorative Therapies, Inc
Via Globe NewsWire
Obesity And Back Pain: BioRestorative Therapies Inc. Is Working To Address 2 Common Ailments That Plague Americans with a Major Near Term Data Catalyst
Via News Direct
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.